Status:
COMPLETED
Biomarkers in the Evaluation of Chronic Lung Disease
Lead Sponsor:
Northwell Health
Conditions:
Pulmonary Hypertension
Pulmonary Arterial Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
We hypothesize that hypoxia-induced pulmonary vascular remodeling is mediated by macrophage migration inhibitory factor (MIF), that remodeling is in fact the reflection of a chronic inflammatory proce...
Detailed Description
We hypothesize that hypoxia-induced pulmonary vascular remodeling is mediated by macrophage migration inhibitory factor (MIF), that remodeling is in fact the reflection of a chronic inflammatory proce...
Eligibility Criteria
Inclusion
- Subject are at least 18 years of age
- Subject has confirmed Pulmonary Hypertension and Interstitial Lung Disease
- Subject are able to complete study procedures, such as spirometry, and Pulmonary Exercise test.
Exclusion
- Subject are pregnant
- Subject is unable to perform tasks associated with study
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT00926523
Start Date
June 1 2009
End Date
March 1 2011
Last Update
May 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Interstitial Lung Disease and Pulmonary Hypertension Programs
New Hyde Park, New York, United States, 11040